Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials

BACKGROUND: The role of neoadjuvant chemotherapy (NC) in resectable pancreatic cancer (RPC) has yet to be defined. This review aims to analyze the benefit of NC in RPC compared with upfront surgery (US) in terms of overall survival (OS) and disease-free survival (DFS). PATIENTS AND METHODS: PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanem, I., Lora, D., Herradón, N., de Velasco, G., Carretero-González, A., Jiménez-Varas, M.Á., Vázquez de Parga, P., Feliu, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117867/
https://www.ncbi.nlm.nih.gov/pubmed/35580504
http://dx.doi.org/10.1016/j.esmoop.2022.100485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117867/
https://www.ncbi.nlm.nih.gov/pubmed/35580504
http://dx.doi.org/10.1016/j.esmoop.2022.100485

Ejemplares similares